收藏切换
Analysis technology and application progress of therapeutic monoclonal antibody drugs
收藏切换
Guo-lin ZHANG1, Rong-xian JING2, Le GUO3, Yi-wen XING1, Man XUE1
Chinese Journal of New Drugs | 2021, 30(6) : 528 - 534
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(6): 528-534
Analysis technology and application progress of therapeutic monoclonal antibody drugs
Full
Guo-lin ZHANG1, Rong-xian JING2, Le GUO3, Yi-wen XING1, Man XUE1
Affiliations
  • 1Suzhou Institute for Drug Control, Suzhou 215000, China
  • 2Suzhou Municipal Hospital, Suzhou 215000, China
  • 3Ningxia Medical University, Yinchuan 750004, China
Published: 2021-03-30
Outline
收藏切换

Therapeutic monoclonal antibody (mAb) drugs are highly homogeneous bio-macromolecules, with high degree of homogeneity in antigen epitopes, physical and chemical properties and biological activities, which can specifically bind to the target molecules. In the course of treatment, the incidence of adverse reactions is low while the tolerance of patients is high. Monoclonal antibodies are the focus in the field of bio-pharmaceutics, which have become the most important and fastest growing area in modern biopharmaceutical industry. According to the different production process and technology, the development of monoclonal antibodies has experienced four generations. Sintilimab injection, treprizumab injection, carrizumab for injection and tirizumab injection recently approved in China are all the third generation of humanized monoclonal antibody drugs. The molecular structure of monoclonal antibody drugs is complex, which is easy to change the heterogeneity of dimer, polymer and terminal amino acid mutation. These changes may cause serious effects on the safety and effectiveness of clinical medication. It is an important measure to control the quality of the original and finished products of monoclonal anti-tumor drugs to ensure the safety and effectiveness of such products. At present, the main methods of quality control and analysis of monoclonal antibody products include HPLC, ELISA, CZE, cIEF, iCIEF and CE-SDS. In this paper, the analysis methods for quality control and application status of monoclonal antibodies were reviewed, which can provide reference for related research and product quality control.

monoclonal antibody  /  high performance liquid chromatography  /  enzyme linked immunosorbent assay  /  capillary zone electrophoresis  /  capillary isoelectric polycarbonate electrophoresis  /  sodium dodecyl sulfate capillary electrophoresis
张国林, 景荣先, 郭乐, 邢以文, 薛满. 治疗性单克隆抗体类药物分析技术及其应用. 中国新药杂志, 2021 , 30 (6) : 528 -534 .
Guo-lin ZHANG, Rong-xian JING, Le GUO, Yi-wen XING, Man XUE. Analysis technology and application progress of therapeutic monoclonal antibody drugs[J]. Chinese Journal of New Drugs, 2021 , 30 (6) : 528 -534 .
Year 2021 volume 30 Issue 6
34
10
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-29
  • Published:2021-03-30
Article Data
Affiliations
History
  • Accepted:2020-04-07
Funding
Affiliations
    1Suzhou Institute for Drug Control, Suzhou 215000, China
    2Suzhou Municipal Hospital, Suzhou 215000, China
    3Ningxia Medical University, Yinchuan 750004, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT